Evidence map›Paper›PMID 20213102›Full record

ArticleCurrent microbiology2010

Loss of IrpT function in Lactococcus lactis subsp. lactis N8 results in increased nisin resistance.

Zhengzheng Xuanyuan, Zhenzhou Wu, Ruiqing Li, Dezhou Jiang, Junjie Su, Haijin Xu, Yanling Bai, Xiuming Zhang, Per Erik Joakim Saris, Mingqiang Qiao

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. TheCurrent research in microbial sciences · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Lantibiotic resistance.Microbiology and molecular biology reviews : MMBR · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Zhengzheng XuanyuanCollege of Life Sciences, Nankai University, Tianjin, China. xuanyuanzheng@yahoo.com.cn
Zhenzhou Wu
Ruiqing Li
Dezhou Jiang
Junjie Su
Haijin Xu
Yanling Bai
Xiuming Zhang
Per Erik Joakim Saris
Mingqiang Qiao
Nankai University · CNUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antibiotic nisin, produced by Lactococcus lactis subsp. lactis N8, offers an extensive commercial prospect as natural food preservatives. The nisin immunity of the L. lactis strains is regulated by a variety of mechanisms. In this study, we isolated a L. lactis L31 strain with increased nisin resistance from a mini-Mu transposon mutant pool of strain N8. The single Mu insertion in strain L31 was in the irpT gene with unknown function. By comparing the proteomic profiles of L. lactis L31 and its parental strain, we found that changes occurred in the synthesis of a protein involved in cell wall biosynthesis (RmlD). Strain L31 had 13.7% higher content of rhamnose in the cell wall than the N8 strain. Overexpression of RmlD involved in the synthesis of dTDP-L: -rhamnose in the nisin-sensitive MG1363 strain increased nisin resistance of the strain. The results indicate that these cellular proteins effected nisin resistance in L. lactis N8.

Indexed as

Genes, BacterialAnti-Bacterial AgentsBacterial ProteinsBlotting, SouthernCell WallDrug Resistance, BacterialElectrophoresis, Gel, Two-DimensionalGene ExpressionLactococcus lactisLipoproteinsMembrane ProteinsMembrane Transport ProteinsNisinPlasmidsPolymerase Chain ReactionProtein Processing, Post-TranslationalAnti-Bacterial AgentsBacterial ProteinsLipoproteinsMembrane ProteinsMembrane Transport ProteinsNisinNisI protein, Lactococcus lactisNisT protein, Lactococcus lactis

Identifiers

PMID20213102
OpenAlexW2071006830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.